What role does AMH play in blood sugar?

Anti-Müllerian hormone (AMH) is primarily a clinical marker of ovarian reserve, reflecting the pool of growing follicles. The provided context does not contain direct evidence linking AMH to blood sugar regulation. Emerging research suggests associations between AMH and metabolic parameters such as insulin resistance and metabolic syndrome, particularly in women with polycystic ovary syndrome (PCOS). Some studies report inverse correlations between AMH levels and fasting insulin or HOMA-IR. However, AMH is not a standard biomarker for glucose metabolism; established tests like HbA1c, fasting glucose, and oral glucose tolerance tests are used for that purpose. The evidence is mixed and largely based on observational studies with moderate strength. A direct causal role of AMH in blood sugar homeostasis has not been demonstrated. Therefore, AMH should not be used as a surrogate marker for glycemic control or diabetes risk. For accurate assessment of glucose metabolism, validated clinical tests are necessary.